Purchase Order 75F40124P00300
Award Date
7/12/24
Potential Completion Date
7/13/29
Potential Value
$574K
Federal Agency
Food and Drug Administration
Awardee
PAK Biosolutions, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for an Integrated Continuous Purification System, awarded by the Food and Drug Administration (FDA) to PAK Biosolutions, Inc., a woman-owned small business manufacturer of biopharmaceutical equipment and solutions. The $504,772 firm-fixed price purchase order contract has a completion date of February 22, 2028 and was designated as a total small business set-aside. PAK Biosolutions specializes in continuous manufacturing instruments and integrated bioprocessing...
The Department of Health and Human Services Food and Drug Administration awarded a $25,000 purchase order contract to PAK Biosolutions, Inc. for PAK Biosolutions parts and components. The contract has a firm fixed price and will be performed in Vienna, Virginia over a three-month period concluding in early November 2023. No additional details were provided regarding subcontractors or the FDA's programs and requirements being supported through this procurement of biological solution parts.
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to R & D Enterprises, Inc., a for-profit small business. The contract, worth $95,980.00, is for the delivery of various scientific instruments and accessories used in bio-processing, research, and testing, such as mass spectrometers, thermal conductivity testers, rheometers, colorimeters, thermomechanical analyzers, and titration calorimeters. The contract has an...
This federal contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of a Sequel IIE long-read DNA/RNA sequencer system and associated consumables. The $726,318.04 firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to support the National Antimicrobial Resistance Monitoring System. The award is directly related to a previous FDA solicitation that sought a long-read sequencing instrument with a minimum...
This is a $355,941 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Pion Inc., a for-profit manufacturer of scientific instrumentation and testing services based in Billerica, Massachusetts. The contract is for the delivery of a "Biorelevant Characterization System for Subcutaneous Formulations" to support the FDA's research and development efforts. The contract does not have a set-aside designation. Pion Inc. has previously secured multiple...
This federal contract award by the Food and Drug Administration (FDA) is for a SAMPLE CONCENTRATOR SYSTEM, a specialized scientific instrument used in laboratory research and analysis. The $10,032.39 firm fixed-price contract was awarded to Biotage, LLC, a small business manufacturer of analytical chemistry equipment. The contract has a January 30, 2015 completion date. While no larger contract vehicle is mentioned, the award appears to be part of the FDA's broader efforts to equip its...
This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
This is a $504,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for a standard PacBio service contract with a base period plus four option years. The contract is for the provision of PART NUMBER 100-236-400 and is not set aside. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support genomic...
The Food and Drug Administration (FDA) awarded a $947,868.05 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for the delivery of a high-resolution ion mobility-high resolution mass spectrometer (HRIM-HRMS) system. This system will expand the FDA's analytical capabilities for ensuring the safety and efficacy of complex drugs like biologics, peptides, and oligonucleotides. The contract has a completion date of January 31, 2024 and includes training,...
The U.S. Food and Drug Administration (FDA) awarded a $40,473.60 firm fixed-price purchase order to Pacific Biosciences of California, Inc. (PacBio), a small business manufacturer, to provide reagents and consumables for the agency's PacBio Revio sequencing instrument system. This order was issued under a $1 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract that PacBio holds with the FDA for sequencing reagents, kits, and consumables to support the agency's genomic...